Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Takeda: 12 NMEs Poised To Launch In Five Years, And Deliver $10 Bn In Peak Sales

Nov 19 2019

• By Jessica Merrill

KONSKIE, POLAND - JULY 21, 2018: Takeda Pharmaceutical company website displayed on a modern smartphone - Image — Takeda updated investors on its pipeline progress • Source: Shutterstock

Related Content

Takeda Shareholders Approve Weber As COO, Setting Up Leadership Handover

Jun 27 2014

Takeda Acquires Ariad In $5.2bn Deal – US Infrastructure A Key Component?

Jan 10 2017

Asia Deal Watch: Ambrx, NovoCodex Partner On Second ADC Candidate, For CD70-Positive Cancers

Nov 07 2019

New Takeda R&D Collabs Aim To Boost IO Pipeline

Jan 04 2019

Related Companies

Takeda Pharmaceutical Co. Ltd.

Takeda Pharmaceutical Co. Ltd.

Takeda Pharmaceutical Co. Ltd.

ARIAD Pharmaceuticals, Inc.

Novartis AG

Additional Topics

Business Strategies ImmunoOncology Research & Development Cancer BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.